Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1978 1
1980 1
1982 1
1983 1
1985 6
1986 8
1987 5
1988 3
1989 6
1990 10
1991 8
1992 15
1993 20
1994 19
1995 13
1996 14
1997 18
1998 11
1999 27
2000 29
2001 15
2002 30
2003 39
2004 32
2005 21
2006 34
2007 31
2008 33
2009 27
2010 26
2011 29
2012 22
2013 22
2014 25
2015 21
2016 22
2017 30
2018 22
2019 17
2020 16
2021 18
2022 20
2023 14
2024 21
2025 15
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

768 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study.
Ortiz M, Martín A, Arribas F, Coll-Vinent B, Del Arco C, Peinado R, Almendral J; PROCAMIO Study Investigators. Ortiz M, et al. Eur Heart J. 2017 May 1;38(17):1329-1335. doi: 10.1093/eurheartj/ehw230. Eur Heart J. 2017. PMID: 27354046 Free PMC article. Clinical Trial.
AIMS: Intravenous procainamide and amiodarone are drugs of choice for well-tolerated ventricular tachycardia. However, the choice between them, even according to Guidelines, is unclear. ...Tachycardia terminated within 40 min in 22 (67%) procainamide and 11 (38%) amioda …
AIMS: Intravenous procainamide and amiodarone are drugs of choice for well-tolerated ventricular tachycardia. However, the choice bet …
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Bardy GH, et al. N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399. N Engl J Med. 2005. PMID: 15659722 Free article. Clinical Trial.
Placebo and amiodarone were administered in a double-blind fashion. The primary end point was death from any cause. ...CONCLUSIONS: In patients with NYHA class II or III CHF and LVEF of 35 percent or less, amiodarone has no favorable effect on survival, whereas sing …
Placebo and amiodarone were administered in a double-blind fashion. The primary end point was death from any cause. ...CONCLUSIONS: I …
Amiodarone and/or lidocaine for cardiac arrest: A Bayesian network meta-analysis.
Zhao H, Fan K, Feng G. Zhao H, et al. Am J Emerg Med. 2020 Oct;38(10):2185-2193. doi: 10.1016/j.ajem.2020.06.074. Epub 2020 Jul 5. Am J Emerg Med. 2020. PMID: 33071078
In terms of survival to hospital discharge, amiodarone (OR 1.18, 95% CrI 1.03-1.35) and lidocaine (OR 1.22, 95% CrI 1.06-1.41) were more effective than placebo. Amiodarone (OR 1.20, 95% CrI 1.02-1.41) was significantly better than placebo in favorable neurological o …
In terms of survival to hospital discharge, amiodarone (OR 1.18, 95% CrI 1.03-1.35) and lidocaine (OR 1.22, 95% CrI 1.06-1.41) were m …
Amiodarone and beta-blocker combination therapy versus beta-blocker monotherapy for ICD shock prevention: A meta-analysis.
Yazdi V, Moustafa A, Nawras M, Yazdi B, Chacko P. Yazdi V, et al. Pacing Clin Electrophysiol. 2024 Jul;47(7):905-913. doi: 10.1111/pace.15027. Epub 2024 Jun 17. Pacing Clin Electrophysiol. 2024. PMID: 38884634
The aim of this systematic review and meta-analysis is to determine if combined amiodarone and BB therapy improves prevention of ICD shock delivery compared to BB monotherapy. ...A combination therapy of amiodarone and BB was not associated with any further reductio …
The aim of this systematic review and meta-analysis is to determine if combined amiodarone and BB therapy improves prevention of ICD …
Prevalence of amiodarone-induced hypothyroidism; A systematic review and meta-analysis.
Mohammadi K, Shafie D, Vakhshoori M, Bondariyan N, Rezvanian H, Heidarpour M. Mohammadi K, et al. Trends Cardiovasc Med. 2023 May;33(4):252-262. doi: 10.1016/j.tcm.2022.01.001. Epub 2022 Jan 11. Trends Cardiovasc Med. 2023. PMID: 35026394
Amiodarone is a common anti-arrhythmic agent mostly used to treat and prevent different kinds of arrhythmia with several considerable side effects, most commonly on the thyroid gland. We aimed to assess the frequency of hypothyroidism among chronic amiodarone users. …
Amiodarone is a common anti-arrhythmic agent mostly used to treat and prevent different kinds of arrhythmia with several considerable …
Amiodarone or Implantable Cardioverter-Defibrillator in Chagas Cardiomyopathy: The CHAGASICS Randomized Clinical Trial.
Martinelli-Filho M, Marin-Neto JA, Scanavacca MI, de Paola AAV, Medeiros PTJ, Owen R, Pocock SJ, de Siqueira SF; CHAGASICS investigators. Martinelli-Filho M, et al. JAMA Cardiol. 2024 Dec 1;9(12):1073-1081. doi: 10.1001/jamacardio.2024.3169. JAMA Cardiol. 2024. PMID: 39356542 Free PMC article. Clinical Trial.
There were 60 deaths (38.2%) in the ICD arm and 64 (38.6%) in the amiodarone group (hazard ratio [HR], 0.86 [95% CI, 0.60-1.22]; P = .40). The rates of SCD (6 [3.8%] vs 23 [13.9%]; HR, 0.25 [95% CI, 0.10-0.61]; P = .001), bradycardia requiring pacing (3 [1.9%] vs 27 [16.3% …
There were 60 deaths (38.2%) in the ICD arm and 64 (38.6%) in the amiodarone group (hazard ratio [HR], 0.86 [95% CI, 0.60-1.22]; P = …
Amiodarone and cardiac arrest: Systematic review and meta-analysis.
Laina A, Karlis G, Liakos A, Georgiopoulos G, Oikonomou D, Kouskouni E, Chalkias A, Xanthos T. Laina A, et al. Int J Cardiol. 2016 Oct 15;221:780-8. doi: 10.1016/j.ijcard.2016.07.138. Epub 2016 Jul 9. Int J Cardiol. 2016. PMID: 27434349
INTRODUCTION: The 2015 Guidelines for Resuscitation recommend amiodarone as the antiarrhythmic drug of choice in the treatment of resistant ventricular fibrillation or pulseless ventricular tachycardia. ...CONCLUSIONS: Amiodarone significantly improves survival to h …
INTRODUCTION: The 2015 Guidelines for Resuscitation recommend amiodarone as the antiarrhythmic drug of choice in the treatment of res …
Combination prophylactic amiodarone with beta-blockers versus beta-blockers in atrial fibrillation after cardiac surgery: A systematic-review and meta-analysis.
Polintan ET, Monsalve R, Menghrajani RH, Sirilan KY, Nayak SS, Abdelmaseeh P, Patarroyo-Aponte G, Lo KB, Dani SS. Polintan ET, et al. Heart Lung. 2023 Nov-Dec;62:256-263. doi: 10.1016/j.hrtlng.2023.08.006. Epub 2023 Aug 22. Heart Lung. 2023. PMID: 37619317 Review.
BACKGROUND: Guideline recommendations regarding the preferred preventive measures for postoperative atrial fibrillation (POAF) are unclear, nor have we found any review articles addressing the combination of amiodarone and beta-blockers for the prevention of POAF. OBJECTIV …
BACKGROUND: Guideline recommendations regarding the preferred preventive measures for postoperative atrial fibrillation (POAF) are unclear, …
Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis.
Stein C, Migliavaca CB, Colpani V, da Rosa PR, Sganzerla D, Giordani NE, Miguel SRPS, Cruz LN, Polanczyk CA, Ribeiro ALP, Falavigna M. Stein C, et al. PLoS Negl Trop Dis. 2018 Aug 20;12(8):e0006742. doi: 10.1371/journal.pntd.0006742. eCollection 2018 Aug. PLoS Negl Trop Dis. 2018. PMID: 30125291 Free PMC article.
Ventricular arrhythmias are common in patients with Chagas cardiomyopathy, and amiodarone has been widely used for this purpose. The aim of our study was to assess the effect of amiodarone in patients with Chagas cardiomyopathy. ...Although our findings support the …
Ventricular arrhythmias are common in patients with Chagas cardiomyopathy, and amiodarone has been widely used for this purpose. The …
Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death.
Claro JC, Candia R, Rada G, Baraona F, Larrondo F, Letelier LM. Claro JC, et al. Cochrane Database Syst Rev. 2015 Dec 8;2015(12):CD008093. doi: 10.1002/14651858.CD008093.pub2. Cochrane Database Syst Rev. 2015. PMID: 26646017 Free PMC article.
MAIN RESULTS: We included 24 studies (9,997 participants). Seventeen studies evaluated amiodarone for primary prevention and six for secondary prevention. Only three studies used an ICD concomitantly with amiodarone for the comparison (all of them for secondary prev …
MAIN RESULTS: We included 24 studies (9,997 participants). Seventeen studies evaluated amiodarone for primary prevention and six for …
768 results